Hikma Pharmaceuticals PLC header image

Hikma Pharmaceuticals PLC

HIK

Equity

ISIN GB00B0LCW083 / Valor 2324471

LSE London Stock Exchange, SETS (2026-02-20)

GBP 16.33-0.43%

Hikma Pharmaceuticals PLC
UMushroom community rating:

3.09 3 votes No rating yet

NegativeNeutralPositive

About company

Hikma Pharmaceuticals PLC is a leading pharmaceutical company in the MENA region, supplying branded generics and in-licensed patented products to retail and hospital customers. With a global presence, the company operates 29 manufacturing plants, eight R&D centers, and employs approximately 9,100 people worldwide. Hikma manufactures and supplies over 760 products essential for healthcare professionals in North America, MENA, and Europe, catering to the needs of hospitals, physicians, and pharmacists.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-28.4%1Y

-7.66%3Y

-30.8%5Y

Performance

28.5%1Y

24.5%3Y

26.7%5Y

Volatility

4884 M

Market cap (USD)

660,928

Daily traded volume (Shares)

19.9 / 19.68

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.09

3 votes

Performance:

3.09

Innovation:

3.09

Society:

3.09

Nature:

3.09

Moska Ahmadzai

United Kingdom, 26 Oct 2025

Has not generated positive returns recently

Brooklyn Fu

United Kingdom, 20 Oct 2025

secure

Francesco Cuviello

Switzerland, 30 Mar 2025

Interessante Anlage

EQUITIES OF THE SAME SECTOR

Maternus-Kliniken AG

Maternus-Kliniken AG Valor: 335800

Annual Return

-50%0%+50%

Risk level

110

-2.06%EUR 0.95

QuidelOrtho Corporation

QuidelOrtho Corporation Valor: 119356965

Annual Return

-50%0%+50%

Risk level

110

-5.74%USD 21.19

iRhythm Technologies Inc

iRhythm Technologies Inc Valor: 34117792

Annual Return

-50%0%+50%

Risk level

110

-6.45%USD 141.22

Novartis Inc

Novartis Inc Valor: 1200526

Annual Return

-50%0%+50%

Risk level

110

1.20%CHF 127.98

Savaria Corp

Savaria Corp Valor: 1385257

Annual Return

-50%0%+50%

Risk level

110

0.16%CAD 25.75

Johnson & Johnson

Johnson & Johnson Valor: 943981

Annual Return

-50%0%+50%

Risk level

110

1.38%USD 245.84

Novo Nordisk A/S

Novo Nordisk A/S Valor: 461641

Annual Return

-50%0%+50%

Risk level

110

-16.43%USD 39.63

Merck & Co Inc

Merck & Co Inc Valor: 10683053

Annual Return

-50%0%+50%

Risk level

110

1.28%USD 123.82

Pfizer Inc

Pfizer Inc Valor: 962004

Annual Return

-50%0%+50%

Risk level

110

1.54%USD 27.06

Abbott Laboratories

Abbott Laboratories Valor: 903037

Annual Return

-50%0%+50%

Risk level

110

2.74%USD 115.29

SIX

FactSet

Clearbit

Logos provided by Clearbit